Overview
Hyuma Makizako practices in Kagoshima, Japan. Makizako is rated as an Experienced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are Muscle Atrophy, Memory Loss, Dementia, and Excessive Daytime Sleepiness.
Their clinical research consists of co-authoring 223 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 12 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- DementiaMakizako isAdvanced. Learn about Dementia.
- Memory LossMakizako isAdvanced. Learn about Memory Loss.
- Muscle AtrophyMakizako isAdvanced. Learn about Muscle Atrophy.
- Experienced
- Alzheimer's DiseaseMakizako isExperienced. Learn about Alzheimer's Disease.
- AnosmiaMakizako isExperienced. Learn about Anosmia.
- Chronic PainMakizako isExperienced. Learn about Chronic Pain.
- COVID-19Makizako isExperienced. Learn about COVID-19.
- Developmental Dysphasia FamilialMakizako isExperienced. Learn about Developmental Dysphasia Familial.
- Excessive Daytime SleepinessMakizako isExperienced. Learn about Excessive Daytime Sleepiness.